论文信息 - COVID-19-associated risks and effects in myasthenia gravis (CARE-MG) - 字舞流文

COVID-19-associated risks and effects in myasthenia gravis (CARE-MG)

H. Wiendl | M. Maas | J. Vissing | R. Mantegazza | J. Tavee | M. Farrugia | J. Howard | I. Illa | B. Roy | A. Amato | H. Kaminski | J. Caress | K. Utsugisawa | J. Pritchard | G. Burke | Victoria Marshall | P. Maddison | J. Guptill | S. Nafissi | A. Guidon | S. Jacob | H. Murai | S. Muppidi | M. Kaku | R. Nowak | Mahtab Ramezani | A. Tyagi | A. Sousa | A. Pinto | S. Viegas | Ikjae Lee | M. Hehir | G. Cutter | D. Dodig | S. Saba | P. A. Ambrose | Yingkai Li | G. Cutter | M. Maas | C. Carmichael | Amanda C Alok Ana Paula Anthony A Ashwin Bhaskar Caroline Guidon Tyagi Sousa Amato Pinto Roy Carmich | Kamla Best | Natalia Jiménez Esquivel | Paul Gallagher | Rocio Vazquez Do Campo | Shannon Itoyama | H. Wiendl | S. Jacob | Mathew Maas | Renato Mantegazza | H. Wiendl | James F. Howard | Saiju Jacob | H. Murai | Srikanth Muppidi | Y. Li | Amanda C Guidon | Henry J. Kaminski | Gary R Cutter | Matthew B Maas | Isabel Illa | K. Utsugisawa | Richard J. Nowak | Mathew Maas

[1] A. Bar-Or,et al. Neurological immunotherapy in the era of COVID-19 — looking for consensus in the literature , 2020, Nature Reviews Neurology.

[2] H. Wiendl,et al. Guidance for the management of myasthenia gravis (MG) and Lambert-Eaton myasthenic syndrome (LEMS) during the COVID-19 pandemic , 2020, Journal of the Neurological Sciences.

[3] Zunyou Wu,et al. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. , 2020, JAMA.

[4] K. Hartmann,et al. [Exacerbation of pseudoparalytic myasthenia gravis following azithromycin (Zithromax)]. , 1996, Swiss medical weekly.

[5] W. Robberecht,et al. Myasthenic syndrome caused by direct effect of chloroquine on neuromuscular junction. , 1989, Archives of neurology.